miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
很抱歉, 生成此内容时发生错误。

EasySep™小鼠TIL(CD45)正选试剂盒



沪公网安备31010102008431号